rs147681220

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_198576.4(AGRN):​c.5223C>T​(p.Gly1741Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00556 in 1,592,094 control chromosomes in the GnomAD database, including 112 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0077 ( 25 hom., cov: 33)
Exomes 𝑓: 0.0053 ( 87 hom. )

Consequence

AGRN
NM_198576.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.25

Publications

0 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 1-1050807-C-T is Benign according to our data. Variant chr1-1050807-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 474144.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.25 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00774 (1178/152182) while in subpopulation NFE AF = 0.00546 (371/67974). AF 95% confidence interval is 0.005. There are 25 homozygotes in GnomAd4. There are 761 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.5223C>T p.Gly1741Gly synonymous_variant Exon 30 of 36 ENST00000379370.7 NP_940978.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.5223C>T p.Gly1741Gly synonymous_variant Exon 30 of 36 1 NM_198576.4 ENSP00000368678.2
AGRNENST00000651234.1 linkc.4908C>T p.Gly1636Gly synonymous_variant Exon 29 of 38 ENSP00000499046.1
AGRNENST00000652369.2 linkc.4908C>T p.Gly1636Gly synonymous_variant Exon 29 of 35 ENSP00000498543.1
AGRNENST00000620552.4 linkc.4809C>T p.Gly1603Gly synonymous_variant Exon 30 of 39 5 ENSP00000484607.1

Frequencies

GnomAD3 genomes
AF:
0.00775
AC:
1178
AN:
152064
Hom.:
25
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000676
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00309
Gnomad SAS
AF:
0.00477
Gnomad FIN
AF:
0.0647
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00546
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00793
AC:
1680
AN:
211816
AF XY:
0.00775
show subpopulations
Gnomad AFR exome
AF:
0.000534
Gnomad AMR exome
AF:
0.00486
Gnomad ASJ exome
AF:
0.000323
Gnomad EAS exome
AF:
0.000489
Gnomad FIN exome
AF:
0.0552
Gnomad NFE exome
AF:
0.00592
Gnomad OTH exome
AF:
0.0100
GnomAD4 exome
AF:
0.00533
AC:
7681
AN:
1439912
Hom.:
87
Cov.:
34
AF XY:
0.00535
AC XY:
3827
AN XY:
715272
show subpopulations
African (AFR)
AF:
0.000511
AC:
17
AN:
33238
American (AMR)
AF:
0.00501
AC:
213
AN:
42490
Ashkenazi Jewish (ASJ)
AF:
0.000816
AC:
21
AN:
25750
East Asian (EAS)
AF:
0.000308
AC:
12
AN:
39024
South Asian (SAS)
AF:
0.00481
AC:
404
AN:
83988
European-Finnish (FIN)
AF:
0.0522
AC:
2390
AN:
45822
Middle Eastern (MID)
AF:
0.00366
AC:
16
AN:
4366
European-Non Finnish (NFE)
AF:
0.00389
AC:
4301
AN:
1105654
Other (OTH)
AF:
0.00515
AC:
307
AN:
59580
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
431
862
1292
1723
2154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00774
AC:
1178
AN:
152182
Hom.:
25
Cov.:
33
AF XY:
0.0102
AC XY:
761
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.000674
AC:
28
AN:
41516
American (AMR)
AF:
0.00262
AC:
40
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00310
AC:
16
AN:
5164
South Asian (SAS)
AF:
0.00477
AC:
23
AN:
4822
European-Finnish (FIN)
AF:
0.0647
AC:
687
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00546
AC:
371
AN:
67974
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
60
120
179
239
299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00602
Hom.:
3
Bravo
AF:
0.00272
Asia WGS
AF:
0.00635
AC:
22
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AGRN: BP4, BP7, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 02, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

AGRN-related disorder Benign:1
May 02, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Congenital myasthenic syndrome 8 Benign:1
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.27
DANN
Benign
0.74
PhyloP100
-1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147681220; hg19: chr1-986187; COSMIC: COSV101038847; COSMIC: COSV101038847; API